Bioline Rx Ltd ADR (NASDAQ:BLRX)’s Stock Performance and Outlook

In the latest trading session,, 1.01 million Bioline Rx Ltd ADR (NASDAQ:BLRX) shares changed hands as the company’s beta touched 1.51. With the company’s most recent per share price at $0.68 changed hands at -$0.01 or -0.04% at last look, the market valuation stands at $54.73M. BLRX’s current price is a discount, trading about -272.06% off its 52-week high of $2.53. The share price had its 52-week low at $0.55, which suggests the last value was 19.12% up since then. When we look at Bioline Rx Ltd ADR’s average trading volume, we note the 3-month average coming to 413.49K.

Bioline Rx Ltd ADR (NASDAQ:BLRX) trade information

Instantly BLRX was in red as seen in intraday trades today. With action 10.05%, the performance over the past five days has been green. The drop to weekly highs of 0.7300 subtracted -0.04% to the stock’s daily price. The company’s shares are showing year-to-date downside of -56.39%, with the 5-day performance at 10.05% in the green. However, in the 30-day time frame, Bioline Rx Ltd ADR (NASDAQ:BLRX) is 11.95% up.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free

Bioline Rx Ltd ADR (BLRX) estimates and forecasts

Data shows that the Bioline Rx Ltd ADR share is performing relatively much not better than most of its peers within the same industry. As can be gleaned from the statistics, the company’s share value shot -54.05% over the past 6 months, a -9.57% in annual growth rate that is considerably lower than the industry average of 13.40%. Year-over-year growth is forecast to reach 199.20% up from the last financial year.

Consensus estimates given by 1 financial analysts project the company’s revenue in the current quarter to hit an average of 340k. 1 analysts are of the opinion that Bioline Rx Ltd ADR’s revenue for the current quarter will be 470k.

Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of 21.53%. The 2024 estimates are for Bioline Rx Ltd ADR earnings to decrease by -15.02%.

BLRX Dividends

Bioline Rx Ltd ADR is expected to release its next quarterly earnings report in June.